Literature DB >> 31486896

Lung function evolution in children with old and new type bronchopulmonary dysplasia: a retrospective cohort analysis.

Frederik Cardoen1, François Vermeulen1, Marijke Proesmans1, Marleen Moens2, Kris De Boeck3.   

Abstract

Bronchopulmonary dysplasia (BPD) is one of the most important sequelae of premature birth. There is concern that in some patients, lung injuries early in life may have lifelong consequences. In this retrospective observational cohort study, lung function evolution in children with BPD was investigated from childhood to young adulthood. Data from 355 pulmonary function tests (PFT) in 24 patients were analyzed, with a median age at first PFT of 7.6 years and at last PFT 18.2 years. FEV1 and FEV1/FVC were below the 5th percentile in respectively 18 and 13/24 patients. Comparing first and last measurement, there was significant worsening in FEV1 from a mean of 71.3% pred (SD 18.3) to 66.7% pred (SD 21.7) (p < 0.05) and in FEV1/FVC from 85.4% pred (SD 15.2) to 79.8% pred (SD 17.3) (p = 0.01). Evaluation of the individual lung function changes with linear regression showed deterioration in FEV1, FVC, and FEV1/FVC in respectively 17, 13, and 17/24 patients. Total group analysis showed significant deterioration in FEV1 (- 0.7%/year, p = 0.002) and FEV1/FVC (- 0.5%/year, p = 0.01). None of the 11 patients born up to 1990 improved in FEV1 vs 7 of the 13 patients born after 1990 (p = 0.006).
Conclusion: This points out to further deterioration of the lung function during childhood in this selected group of children with BPD.What is Known:• Data on longitudinal changes in lung function in children with BPD are scarce.What is New:• In children with BPD at the severe end of the disease spectrum, lung function does not improve over time. On the contrary, in two-thirds of the subjects studied FEV1and FEV1/FVC worsen over time.• Lung function evolution towards adulthood was somewhat more favorable in children born after 1990 compared with those born earlier, probably reflecting improvements in neonatal care in subjects with new type BPD.

Entities:  

Keywords:  Chronic lung disease; Longitudinal; Outcome; Preterm newborn; Spirometry

Mesh:

Year:  2019        PMID: 31486896     DOI: 10.1007/s00431-019-03453-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  23 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance.

Authors:  Manjith Narayanan; John Owers-Bradley; Caroline S Beardsmore; Marius Mada; Iain Ball; Ruslan Garipov; Kuldeep S Panesar; Claudia E Kuehni; Ben D Spycher; Sian E Williams; Michael Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

3.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

Review 4.  Airway function measurements and the long-term follow-up of survivors of preterm birth with and without chronic lung disease.

Authors:  Indra Narang; Eugenio Baraldi; Michael Silverman; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2006-06

5.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

6.  Bronchopulmonary dysplasia: definitions and long-term respiratory outcome.

Authors:  Eugenio Baraldi; Silvia Carraro; Marco Filippone
Journal:  Early Hum Dev       Date:  2009-09-29       Impact factor: 2.079

7.  Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence.

Authors:  Lex W Doyle; Brenda Faber; Catherine Callanan; Nicholas Freezer; Geoffrey W Ford; Noni M Davis
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

8.  On early life risk factors for COPD.

Authors:  Marco Filippone; Eugenio Baraldi
Journal:  Am J Respir Crit Care Med       Date:  2011-02-01       Impact factor: 21.405

9.  Evidence for adult lung growth in humans.

Authors:  James P Butler; Stephen H Loring; Samuel Patz; Akira Tsuda; Dmitriy A Yablonskiy; Steven J Mentzer
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

10.  Inhaled corticosteroids and growth of airway function in asthmatic children.

Authors:  P J F M Merkus; W van Pelt; J C van Houwelingen; L E M van Essen-Zandvliet; E J Duiverman; K F Kerrebijn; P H Quanjer
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

View more
  4 in total

Review 1.  Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm.

Authors:  Joseph W Duke; Adam J Lewandowski; Steven H Abman; Andrew T Lovering
Journal:  J Physiol       Date:  2022-01-12       Impact factor: 6.228

2.  The Consensus Definition of Bronchopulmonary Dysplasia Is an Adequate Predictor of Lung Function at Preschool Age.

Authors:  Segundo Rite; Carlos Martín de Vicente; Juan P García-Iñiguez; María L Couce; María P Samper; Alicia Montaner; Carmen Ruiz de la Cuesta
Journal:  Front Pediatr       Date:  2022-02-04       Impact factor: 3.418

Review 3.  Nutrition of Infants with Bronchopulmonary Dysplasia before and after Discharge from the Neonatal Intensive Care Unit.

Authors:  Ageliki A Karatza; Despoina Gkentzi; Anastasia Varvarigou
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

Review 4.  Respiratory and cardiopulmonary limitations to aerobic exercise capacity in adults born preterm.

Authors:  Joseph W Duke; Andrew T Lovering
Journal:  J Appl Physiol (1985)       Date:  2020-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.